These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 701277)

  • 21. Lymphocytes bearing Fc receptors for IgE. V. Effect of tunicamycin on the formation of IgE-potentiating factor and IgE-suppressive factor by con A-activated lymphocytes.
    Yodoi J; Hirashima M; Ishizaka K
    J Immunol; 1981 Mar; 126(3):877-82. PubMed ID: 6970224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tunicamycin enhances the antiviral and anticellular activity of interferon.
    Maheshwari RK; Sreevalsan T; Silverman RH; Hay J; Friedman RM
    Science; 1983 Mar; 219(4590):1339-41. PubMed ID: 6187067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for role of glycoprotein carbohydrates in membrane transport: specific inhibition by tunicamycin.
    Olden K; Pratt RM; Jaworski C; Yamada KM
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):791-5. PubMed ID: 218220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon treatment inhibits glycosylation of a viral protein.
    Maheshwari RK; Banerjee DK; Waechter CJ; Olden K; Friedman RM
    Nature; 1980 Oct; 287(5781):454-6. PubMed ID: 6159539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epithelial sheet movement: effects of tunicamycin on migration and glycoprotein synthesis.
    Gipson IK; Kiorpes TC; Brennan SJ
    Dev Biol; 1984 Jan; 101(1):212-20. PubMed ID: 6692974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of tunicamycin on production by mouse fibroblast L929 cells of the factor-stimulating differentiation of mouse myeloid leukemic cells and the colony-stimulating factor.
    Yamamoto Y; Tomida M; Hozumi M; Ayusawa D; Seno T; Tamura G
    Cancer Res; 1981 Jun; 41(6):2534-9. PubMed ID: 6972252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of tunicamycin and monensin on biosynthesis, transport, and maturation of bovine herpesvirus type-1 glycoproteins.
    van Drunen Littel-van den Hurk S; Babiuk LA
    Virology; 1985 May; 143(1):104-18. PubMed ID: 2997997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular structure of human fibroblast and leukocyte interferons: probe by lectin and hydrophobic chromatography.
    Jankowski WJ; Davey MW; O'Malley JA; Sulkowski E; Carter WA
    J Virol; 1975 Nov; 16(5):1124-30. PubMed ID: 1185850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The glycoprotein nature of murine gamma interferon.
    Havell EA; Spitalny GL
    Arch Virol; 1984; 80(2-3):195-207. PubMed ID: 6202280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tunicamycin blocks the emergence and maintenance of insulin receptors on mitogen-activated human T lymphocytes.
    Ercolani L; Brown TJ; Ginsberg BH
    Metabolism; 1984 Apr; 33(4):309-16. PubMed ID: 6608656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of differentiation of human and murine myeloid leukemia cells in culture by tunicamycin.
    Nakayasu M; Terada M; Tamura G; Sugimura T
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):409-13. PubMed ID: 6928633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-translational glycosylation-induced activation of aglycoinsulin receptor accumulated during tunicamycin treatment.
    Ronnett GV; Lane MD
    J Biol Chem; 1981 May; 256(10):4704-7. PubMed ID: 7228853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycosylation of herpes simplex virus type 1 gC in the presence of tunicamycin.
    Wenske EA; Courtney RJ
    J Virol; 1983 Apr; 46(1):297-301. PubMed ID: 6298464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trypanosoma brucei brucei: inhibition of glycosylation of the major variable surface coat glycoprotein by tunicamycin.
    Strickler JE; Patton CL
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1529-33. PubMed ID: 6929505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of glycosylation in secretion and membrane expression of immunoglobulins M and A.
    Sitia R; Rubartelli A; Hämmerling U
    Mol Immunol; 1984 Aug; 21(8):709-19. PubMed ID: 6749140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycoprotein nature of yeast alkaline phosphatase. Formation of active enzyme in the presence of tunicamycin.
    Onishi HR; Tkacz JS; Lampen JO
    J Biol Chem; 1979 Dec; 254(23):11943-52. PubMed ID: 500684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-operative nature of N-glycosylation of proteins at multiple sites: evidence from studies with tunicamycin.
    Cushley W; Singer HH; Williamson AR
    Biosci Rep; 1983 Apr; 3(4):331-6. PubMed ID: 6409177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent inhibition by tunicamycin of glycosylation and parasitemia in malarial parasites (Plasmodium falciparum) cultured in human erythrocytes.
    Udeinya IJ; Van Dyke K
    Pharmacology; 1981; 23(3):165-70. PubMed ID: 7025026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective cytotoxicity of purified homologues of tunicamycin on transformed BALB/3T3 fibroblasts.
    Seiberg M; Duksin D
    Cancer Res; 1983 Feb; 43(2):845-50. PubMed ID: 6293705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of tunicamycin on IgM, IgA, and IgG secretion by mouse plasmacytoma cells.
    Hickman S; Kornfeld S
    J Immunol; 1978 Sep; 121(3):990-6. PubMed ID: 690446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.